ArticleMolecular and clinical oncology2017

Complete response to azacitidine priming and nab-paclitaxel in non-Hodgkin lymphoma resistant to biochemotherapy.

Randy C Bowen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.